While genetic predispositions do not predict exact medication response or hypoglycemia risk, they can support a more granular conversation with your provider about your individual metabolic tendencies and monitoring strategy
Key takeaways 1 in 10 college students surveyed reported using semaglutide for weight loss
In many cases, providers apply criteria similar to those used for Wegovy (another semaglutide medication FDA-approved for weight management)
Helping people shed extra pounds and achieve a healthy weight improves a host of other conditions and symptoms, including high blood pressure
Individuals who used Ozempic, Wegovy, or Rybelsus and now struggle with gastroparesis, also known as stomach paralysis, might be entitled to financial compensation, as Novo Nordisk failed to warn of this serious, often irreversible adverse effect
Any one of those seven, if cleared, would push the market past the third-generic threshold Larsen described